β-LACTAMASE INHIBITORS — A NEW APPROACH TO RESISTANCE Newsletter Article 20 February 2013 Pages: 3 - 4
FATAL CARDIOTOXICITY FOLLOWING THIORIDAZINE OVERDOSE Newsletter Article 20 February 2013 Pages: 5 - 5
THE IMPORTANCE OF HYPERTENSION IN HALOPERIDOL POISONING Newsletter Article 20 February 2013 Pages: 5 - 5
MASSIVE PROPYLTHIOURACIL OVERDOSE FOLLOWS A BENIGN COURSE Newsletter Article 20 February 2013 Pages: 5 - 5
LIFE-THREATENING ARRHYTHMIAS POSSIBLY CAUSED BY IV CIMETIDINE Newsletter Article 20 February 2013 Pages: 5 - 6
A LOWER INCIDENCE OF BREAST CANCER ON OESTROGEN REPLACEMENT Newsletter Article 20 February 2013 Pages: 6 - 6
RESERVATIONS ABOUT PROSTAGLANDIN PESSARIES FOR LABOUR INDUCTION Newsletter Article 20 February 2013 Pages: 7 - 7
PERMANENT VESTIBULAR TOXICITY REPORTED WITH TOBRAMYCIN Newsletter Article 20 February 2013 Pages: 7 - 7
NO PLACE FOR LABETALOL MINIBOLUS FOR HYPERTENSIVE ENCEPHALOPATHY Newsletter Article 20 February 2013 Pages: 7 - 8
PROGESTAGENS CORRECT ENDOMETRIAL DISEASE IN WOMEN ON OESTROGEN Newsletter Article 20 February 2013 Pages: 9 - 9
ANTIBIOTICS IN THE TREATMENT OF NEUTROPENIC CANCER PATIENTS Newsletter Article 20 February 2013 Pages: 9 - 10
VARICELLA AND HERPES ZOSTER IN IMMUNOCOMPROMISED PATIENTS Newsletter Article 20 February 2013 Pages: 10 - 10
A VARIETY OF CHALLENGES FOR TOPICAL CORTICOSTEROIDS Newsletter Article 20 February 2013 Pages: 11 - 12
CROTAMITON — AN EFFECTIVE ANSWER TO A TICKLISH PROBLEM Newsletter Article 20 February 2013 Pages: 12 - 12
THERE’S MORE TO CANCER THERAPY THAN MEASURING PLASMA LEVELS Newsletter Article 20 February 2013 Pages: 14 - 14
NADOLOL — A NEW β-BLOCKER WITH THE LONGEST HALF-LIFE YET Newsletter Article 20 February 2013 Pages: 15 - 15
NO NEED TO RESTRICT A MODERATE MILK INTAKE WITH LYMECYCLINE Newsletter Article 20 February 2013 Pages: 16 - 16